Latest news with #Nave
Yahoo
20-04-2025
- Business
- Yahoo
Is It Too Late to Buy Coupang Stock?
South Korean e-commerce company Coupang (NYSE: CPNG) launched its U.S. IPO in March 2021, and those hoping at the time that they had found the next great e-commerce company were likely disappointed. Since Coupang began trading, it has lost more than half of its value. However, that figure includes a recovery of more than 130% from its May 2022 low. The question for investors is whether that increase means investors are too late, or does that indicate investors have time to get in on a long-awaited recovery? Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue » Admittedly, Coupang's growth story may not appear as appealing as companies serving larger markets such as MercadoLibre. Coupang's home market of South Korea has a population of 52 million. Even when one counts Taiwan at 24 million, Coupang's addressable market is less than 100 million, far below MercadoLibre's addressable market of more than 650 million. Also, Coupang's estimated market share of 24% is just marginally above a competitor called Nave, according to WPIC. Nonetheless, it operates more than 100 fulfillment centers within South Korea, placing 70% of the country's population within seven miles of a logistics center. That network can provide same-day or next-day delivery to almost all of South Korea's residents. Coupang's platform allows for efficient orders and fulfillment, while its artificial intelligence (AI) technology can forecast demand spikes and have products ready when customers need them. Furthermore, Coupang bulls will like that Grand View Research estimated the compound annual growth rate (CAGR) for South Korean e-commerce at 22%. That likely means the company will remain in growth mode as it captures more of that market share. Coupang's recent performance has closely reflected that CAGR. Its 2024 revenue of just over $30 billion increased by 24% compared to year-ago levels. Additionally, its 2024 net income of $66 million fell significantly amid a $776 million, one-time income tax benefit in 2023. Still, the company generated just over $1 billion in free cash flow during the year, which places its financial situation in a more favorable light than its net income might indicate. Unfortunately, revenue growth is on track to slow to 14% in 2025 before recovering somewhat to 15% by the next year. Even with the partial recovery, that could bode poorly for the stock, as investors tend to sour on stocks with slowing revenue growth. Also, the valuation metrics offer a mixed picture. Although the effects of the income tax benefit skewed the P/E ratio, Coupang has a price-to-free cash flow ratio of around 39, significantly above the average of 34 for the previous three years. Its price-to-sales (P/S) ratio has remained relatively steady, as its 1.3 sales multiple has shown little variance in recent years. Amid such numbers, one has to assume the stock is slightly expensive. Still, such metrics are unlikely to deter buyers if they perceive Coupang as a lucrative opportunity. Given current conditions, it is probably not too late to buy Coupang stock. However, a bigger question is whether it is too early to buy shares, and it does not look like a lucrative opportunity under current conditions. Coupang launched its IPO in a high-flying bull market, where its e-commerce peers commanded lofty valuations. The stock slid steadily, losing more than 80% of its value by May 2022, so even its 130% "recovery" leaves it far below the stock's all-time high. Admittedly, despite heavy competition and a smaller addressable market, Coupang has prospects for further growth as South Korea and Taiwan further embrace e-commerce. Still, paying a higher valuation when revenue growth is slowing could bring shareholder pain -- an indication that investors should probably refrain from adding shares at this time. Before you buy stock in Coupang, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Coupang wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $524,747!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $622,041!* Now, it's worth noting Stock Advisor's total average return is 792% — a market-crushing outperformance compared to 153% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of April 14, 2025 Will Healy has positions in MercadoLibre. The Motley Fool has positions in and recommends MercadoLibre. The Motley Fool recommends Coupang. The Motley Fool has a disclosure policy. Is It Too Late to Buy Coupang Stock? was originally published by The Motley Fool Sign in to access your portfolio
Yahoo
19-04-2025
- Business
- Yahoo
Is It Too Late to Buy Coupang Stock?
South Korean e-commerce company Coupang (NYSE: CPNG) launched its U.S. IPO in March 2021, and those hoping at the time that they had found the next great e-commerce company were likely disappointed. Since Coupang began trading, it has lost more than half of its value. However, that figure includes a recovery of more than 130% from its May 2022 low. The question for investors is whether that increase means investors are too late, or does that indicate investors have time to get in on a long-awaited recovery? Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue » Admittedly, Coupang's growth story may not appear as appealing as companies serving larger markets such as MercadoLibre. Coupang's home market of South Korea has a population of 52 million. Even when one counts Taiwan at 24 million, Coupang's addressable market is less than 100 million, far below MercadoLibre's addressable market of more than 650 million. Also, Coupang's estimated market share of 24% is just marginally above a competitor called Nave, according to WPIC. Nonetheless, it operates more than 100 fulfillment centers within South Korea, placing 70% of the country's population within seven miles of a logistics center. That network can provide same-day or next-day delivery to almost all of South Korea's residents. Coupang's platform allows for efficient orders and fulfillment, while its artificial intelligence (AI) technology can forecast demand spikes and have products ready when customers need them. Furthermore, Coupang bulls will like that Grand View Research estimated the compound annual growth rate (CAGR) for South Korean e-commerce at 22%. That likely means the company will remain in growth mode as it captures more of that market share. Coupang's recent performance has closely reflected that CAGR. Its 2024 revenue of just over $30 billion increased by 24% compared to year-ago levels. Additionally, its 2024 net income of $66 million fell significantly amid a $776 million, one-time income tax benefit in 2023. Still, the company generated just over $1 billion in free cash flow during the year, which places its financial situation in a more favorable light than its net income might indicate. Unfortunately, revenue growth is on track to slow to 14% in 2025 before recovering somewhat to 15% by the next year. Even with the partial recovery, that could bode poorly for the stock, as investors tend to sour on stocks with slowing revenue growth. Also, the valuation metrics offer a mixed picture. Although the effects of the income tax benefit skewed the P/E ratio, Coupang has a price-to-free cash flow ratio of around 39, significantly above the average of 34 for the previous three years. Its price-to-sales (P/S) ratio has remained relatively steady, as its 1.3 sales multiple has shown little variance in recent years. Amid such numbers, one has to assume the stock is slightly expensive. Still, such metrics are unlikely to deter buyers if they perceive Coupang as a lucrative opportunity. Given current conditions, it is probably not too late to buy Coupang stock. However, a bigger question is whether it is too early to buy shares, and it does not look like a lucrative opportunity under current conditions. Coupang launched its IPO in a high-flying bull market, where its e-commerce peers commanded lofty valuations. The stock slid steadily, losing more than 80% of its value by May 2022, so even its 130% "recovery" leaves it far below the stock's all-time high. Admittedly, despite heavy competition and a smaller addressable market, Coupang has prospects for further growth as South Korea and Taiwan further embrace e-commerce. Still, paying a higher valuation when revenue growth is slowing could bring shareholder pain -- an indication that investors should probably refrain from adding shares at this time. Before you buy stock in Coupang, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Coupang wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $524,747!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $622,041!* Now, it's worth noting Stock Advisor's total average return is 792% — a market-crushing outperformance compared to 153% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of April 14, 2025 Will Healy has positions in MercadoLibre. The Motley Fool has positions in and recommends MercadoLibre. The Motley Fool recommends Coupang. The Motley Fool has a disclosure policy. Is It Too Late to Buy Coupang Stock? was originally published by The Motley Fool Sign in to access your portfolio
Yahoo
03-04-2025
- Yahoo
‘She decided to let him in': Documents reveal what led up to a stabbing, manhunt in Fernandina Beach
Action News Jax has learned more about the man at the center of a 7-hour manhunt in Nassau County. 45-year-old Ryan Daniel Nave is now behind bars without bond, charged with attempted second-degree murder. It was a law enforcement search for Nave that left Fernandina Beach neighbors on edge Wednesday night. Nassau County Sheriff Bill Leeper said Nave stabbed a woman he knew after asking her for food. He is listed as homeless in the county's inmate log. 'The victim did not want to let him in the house. But he wanted something to eat, so she decided to let him in,' said Leeper. The arrest warrant said Nave ran off after other people returned to the home. Court documents detail the bloody scene that deputies found on Robin Hood Drive: 'A female victim, in a bedroom, with 9 major puncture wounds to her head, torso, arms, and legs,' and '13 defensive wounds on her arms and hands.' 'Obviously, it looks like he's got some mental issues too. He's well known in the area. He goes around. If you do what he did, he's nuts,' said Leeper. Court records show Nave has been in prison twice before. He served 13 months for each conviction in Nassau County: One in 2017 for burglary and one for possession of meth in 2018. Along with his current mugshot, Action News Jax found two prior mugshots from Nassau County from earlier this year when he was arrested for trespassing. [DOWNLOAD: Free Action News Jax app for alerts as news breaks] Nave was found in a wooded area about a mile away from the house, after the Sheriff's Office said someone spotted him and called law enforcement. Action News Jax was in Fernandina Beach throughout the search, and one neighbor said he believed he had seen Nave. 'I saw a gentleman on the left-hand side of the road coming out of a ditch,' said David Powell. Powell also said the man was covered in blood. The victim, who has not been identified, was in critical condition at last check. [SIGN UP: Action News Jax Daily Headlines Newsletter] Click here to download the free Action News Jax news and weather apps, click here to download the Action News Jax Now app for your smart TV and click here to stream Action News Jax live.
Yahoo
03-04-2025
- Yahoo
Homeless man arrested following 6-hour manhunt in Fernandina Beach facing murder charge
The man arrested by Nassau County deputies Wednesday following a six-hour manhunt is in jail accused of murder. Ryan Nave, 45, is also facing a charge of felony solicitation, according to Nassau County jail records. >>> STREAM ACTION NEWS JAX LIVE <<< Authorities did not give any details about Wednesday's manhunt for Nave other than he was a suspect in an incident that happened on Robinhood Drive. Nave's address in the county's inmate log is listed as 'homeless.' He is being held on no bond. [DOWNLOAD: Free Action News Jax app for alerts as news breaks] At about 4 p.m. Wednesday, deputies asked for the public's help looking for Nave warning people to not approach him and to call 911 if they see him. The search centered on the area of Robinhood Drive, which is just south of the intersection of Sadler Road and South 14th Street. Nave was taken into custody at about 10 p.m. Read: Man fired 3 shots at victims' car in road rage event, pulled over 9 minutes later Read: St. Marys student hospitalized after students pour hand sanitizer in her water bottle Read: Florida Fish and Wildlife Conservation Commission unveils details of potential 2025 Bear Hunt [SIGN UP: Action News Jax Daily Headlines Newsletter] Click here to download the free Action News Jax news and weather apps, click here to download the Action News Jax Now app for your smart TV and click here to stream Action News Jax live.
Yahoo
30-03-2025
- Business
- Yahoo
23andMe's DNA data is going up for sale. Here's why companies might want it
23andMe, a standard-bearer for the at-home health movement, announced on March 23 that it has filed for Chapter 11 bankruptcy to facilitate a sale, prompting many of its 15 million customers to wonder: What happens to my genetic data now? Privacy advocates and two state attorneys general have urged Americans to delete their data on the service, even as 23andMe said the bankr uptcy won't change how it handles user data. It's unclear what's next for 23andMe, but experts say there's a big incentive for corporations and researchers alike to get their hands on the company's trove of genetic data. Genetics can reveal a lot about a person, from their health predispositions to their food preferences, offering a rare glimpse into details about a person and their family for generations to come. Despite possible privacy issues, genetic data offers huge potential for everything from medical research to advertising. 'Genetic data is permanent and unique,' said Katie Hasson, associate director for the Center for Genetics and Society. 'It could reveal information about people who don't exist until many years from now.' 23andMe says on its website that any buyer must comply with laws around handling customer data. The company plans to continue selling kits and offering subscriptions. Gideon Nave, an associate professor of marketing for the University of Pennsylvania's Wharton School, told CNN that any company looking to personalize their products or advertising would find such data highly useful. For example, genetics can be linked to certain taste preferences in food. Researchers from the University of Edinburgh and Human Technopole, Milan found that hundreds of genetic variants were tied to likings of specific foods. Nave, who co-authored a paper on the potential uses of genetic data in marketing, said genetic data can be more telling than what's in your grocery cart since the purchased items could be for someone else. 'In some cases, genetic data is more informative than even what people say that they eat,' he said. The most obvious use for genetic data is discovering one's health predispositions; 23andMe offers a subscription that shows whether a person's DNA is associated with a likelihood for certain diseases, such as Type 2 diabetes or celiac disease. That's why this type of data could also be helpful for healthcare research and developing personalized medicine, Nave said. There's also promise in combining genetic information with clinical data to make more accurate diagnoses, according to Vasant Dhar, a professor of business and data science at New York University's Stern School of Business. That's why he believes 23andMe's bidders will most likely be interested in using the data for health and medical research. 'Doctors (are) guessing. They're following rules. They're doing tests and they're trying to figure out what's wrong with you,' Dhar said. 'But you know, a lot of the diseases have very similar symptoms.' That also raises the question of whether genetic data could be used elsewhere in the healthcare industry. The Genetic Information Nondiscrimination Act prevents genetic information from being used for discrimination in health insurance coverage or employment. But there aren't many rules or restrictions in place to prevent genetic discrimination in other scenarios, such as disability insurance, according to Hasson. The use of online genetic databases by law enforcement has also raised concerns about personal privacy rights. A 23andMe sale wouldn't be the first time a genetic testing firm has sold itself in recent years; private equity firm Blackstone acquired in 2020. But since genetic data doesn't have an expiration date, companies could use it well into the future, even if it's not being used now, Hasson said. If genetic data were to ever be used in advertising, Nave worries it could potentially be used to target consumers based on certain health traits — possibly ones they're not even aware of. 'One of the dark sides of this space is that with genetics, people know a hell of a lot about you,' said Dhar. 'And, yeah, they could exploit that.' Sign in to access your portfolio
